The Journal of Clinical Psychiatry

Letter to the Editor July 21, 2009

Aripiprazole Treatment of Risperidone-Induced Hyperprolactinemia

; ; ; ; ; ; ; ; ;

J Clin Psychiatry 2009;70(7):1058-1059

Article Abstract

Letter to the Editor

Sir: Hyperprolactinemia is a well-recognized complication
of some antipsychotic agents that results from the blocking of
dopamine-2 (D2) receptors in the anterior pituitary. Aripiprazole,
a potent partial agonist of the D2 receptors, inhibits spontaneous
prolactin release from isolated anterior pituitary slices. Clinically,
switching to aripiprazole monotherapy resolves antipsychoticinduced
hyperprolactinemia.

 

This PDF is free for all visitors!